We are live on ! Find out more
GEA

Glen Eagle Advisors Portfolio holdings

AUM $714M
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+18.87%
3 Year Est. Return
+62.99%
5 Year Est. Return
+76.32%
10 Year Est. Return
AUM
$187M
AUM Growth
+$35.7M
Cap. Flow
+$24M
Cap. Flow %
12.84%
Top 10 Hldgs %
26.94%
Holding
934
New
114
Increased
345
Reduced
72
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.57M
2
AAPL icon
Apple
AAPL
+$873K
3
V icon
Visa
V
+$710K
4
XOM icon
ExxonMobil
XOM
+$669K
5
NOBL icon
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
+$654K

Sector Composition

Rank Sector Weight
1 Technology 9.29%
2 Financials 7.79%
3 Healthcare 6.4%
4 Communication Services 4.68%
5 Industrials 4.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SON icon
776
Sonoco
SON
$5.57B
$2.06K ﹤0.01%
+33
New +$1.95K
SCHX icon
777
Schwab US Large- Cap ETF
SCHX
$70.8B
$2K ﹤0.01%
156
AUY
778
DELISTED
Yamana Gold, Inc.
AUY
$1.98K ﹤0.01%
500
TFI icon
779
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.05B
$1.97K ﹤0.01%
39
JBLU icon
780
JetBlue
JBLU
$1.86B
$1.97K ﹤0.01%
105
ALXN
781
DELISTED
Alexion Pharmaceuticals
ALXN
$1.95K ﹤0.01%
18
CDNS icon
782
Cadence Design Systems
CDNS
$91.1B
$1.94K ﹤0.01%
28
QGEN icon
783
Qiagen
QGEN
$8.55B
$1.93K ﹤0.01%
54
LW icon
784
Lamb Weston
LW
$6.79B
$1.89K ﹤0.01%
+22
New +$1.77K
OLN icon
785
Olin
OLN
$2.69B
$1.85K ﹤0.01%
+107
New +$1.92K
CC icon
786
Chemours
CC
$2.63B
$1.81K ﹤0.01%
100
PARA
787
DELISTED
Paramount Global Class B
PARA
$1.8K ﹤0.01%
+43
New +$1.67K
SDIV icon
788
Global X SuperDividend ETF
SDIV
$1.21B
$1.77K ﹤0.01%
33
STAA icon
789
STAAR Surgical
STAA
$1.2B
$1.76K ﹤0.01%
50
XTL icon
790
State Street SPDR S&P Telecom ETF
XTL
$588M
$1.75K ﹤0.01%
+25
New +$1.7K
VCEL icon
791
Vericel Corp
VCEL
$2.3B
$1.74K ﹤0.01%
100
SONY icon
792
Sony
SONY
$122B
$1.7K ﹤0.01%
125
CMBS icon
793
iShares CMBS ETF
CMBS
$472M
$1.69K ﹤0.01%
+32
New +$1.7K
CGC
794
Canopy Growth
CGC
$382M
$1.69K ﹤0.01%
8
LCTX icon
795
Lineage Cell Therapeutics
LCTX
$267M
$1.66K ﹤0.01%
1,863
UNIT
796
Uniti Group
UNIT
$2.68B
$1.64K ﹤0.01%
200
-150
-43% -$1.08K
SNAP icon
797
Snap
SNAP
$7.42B
$1.63K ﹤0.01%
+100
New +$1.47K
FNDF icon
798
Schwab Fundamental International Large Company Index ETF
FNDF
$24.3B
$1.62K ﹤0.01%
56
RITM icon
799
Rithm Capital
RITM
$5.01B
$1.61K ﹤0.01%
+100
New +$1.57K
SHYG icon
800
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.58B
$1.58K ﹤0.01%
34

Similar funds

Glen Eagle Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Glen Eagle Advisors held 934 positions worth $187M, up 24% from $151M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Glen Eagle Advisors deployed $24M of net new capital in Q4 2019, opening 114 new positions and adding to 345 existing holdings. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 10,743 shares worth $587K.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 7.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $211K trimmed.

  • Glen Eagle Advisors's largest Q4 2019 buy was iShares AAA-A Rated Corporate Bond ETF: 10,743 shares worth $587K.
  • Glen Eagle Advisors added most to Microsoft in Q4 2019, an estimated $1.57M increase.
  • Glen Eagle Advisors's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $211K.
  • Glen Eagle Advisors fully exited Invesco BulletShares 2019 Corporate Bond ETF in Q4 2019, selling an estimated $575K.
  • Glen Eagle Advisors's ten largest holdings make up 27% of its $187M portfolio in Q4 2019.
  • Glen Eagle Advisors opened 114 new positions and closed 33 in Q4 2019.
  • Glen Eagle Advisors's portfolio value rose 24% quarter-over-quarter to $187M.

Based on Glen Eagle Advisors's 13F filing for Q4 2019, filed 13 Aug 2024.